Nizhoni Denipah, MD
Otolaryngology · Santa Fe, NMNPI 1003250069
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,063 of the $7,551 with a category attached, or 80.3%. It is spread thinly across 27 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,570, more than ten times the $115 reported in 2019. Among otolaryngology clinicians in NM with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 117 payments — averaging $64.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Revance Therapeutics, Inc.$2K
- Stryker$1K
- Zimmer Biomet$878
- Kls-martin L.p.$681
- Cochlear Americas$589
- AbbVie$555
- plus $2K from 21 others
What the payments were for
- Speaking & faculty fees$100%
- Travel & lodging$1,47820%
- Food & beverage$6,06380%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Revance Therapeutics, Inc. | 27 | $1,738 |
| Stryker | 6 | $1,245 |
| Zimmer Biomet | 5 | $878 |
| Kls-martin L.p. | 13 | $681 |
| Cochlear Americas | 7 | $589 |
| AbbVie(2 entities) | 6 | $555 |
| Aerin Medical Inc. | 14 | $552 |
| Intersect ENT, Inc. | 3 | $288 |
| Acclarent, Inc | 7 | $221 |
| Integra Lifesciences Corporation | 4 | $214 |
| GSK | 3 | $69 |
| Medtronic | 1 | $68 |
| KARL Storz Endoscopy-america | 1 | $67 |
| Merck | 3 | $60 |
| Daiichi Sankyo Inc. | 2 | $43 |
| Optinose US, Inc. | 3 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $37 |
| Sanofi | 2 | $35 |
| Johnson & Johnson | 1 | $29 |
| Kyowa Kirin, Inc. | 1 | $23 |
| Olympus America Inc. | 1 | $23 |
| Incyte Corporation | 1 | $22 |
| Merz North America, Inc. | 1 | $18 |
| Geron Corporation | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $15 |
| Smith+Nephew | 1 | $15 |
| Caris MPI, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAXXIFY$1,144
- SCOPIS ENT$1,025
- ROSA$668
- Cochlear Nucleus CI632 cochlear implant with Slim Modiolar electrode$274
- Baha$274
- OSIA OSI300 IMPLANT$274
- NATRELLE SALINE-FILLED BREAST IMPLANTS$262
- SHAVER SYSTEM$162
- SAW GUIDE$151
- SINUVA$148
- PROPEL$137
- Acclarent Aera$118
- Inspira Air$118
- RELIEVA SPINPLUS NAV$118
- TruDi Probe$118
How this compares
$7,551 in reported general payments places this provider in the 90th percentile of 39 otolaryngology providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 103 | $2,981 |
| Fluticasone Propionate | 80 | $1,305 |
| Famotidine | 71 | $1,261 |
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 18 | $1,040 |
| Omeprazole | 19 | $585 |
| Ofloxacin | 21 | $553 |
| Ipratropium Bromide | 14 | $437 |
| Mupirocin | 26 | $182 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 18 | $173 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $141 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $72 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Santa Fe
- David BrownSanta Fe$416
- Jason MuddAlbuquerque$9K
- Ryan OroscoAlbuquerque$8K
- Shervin AminpourAlbuquerque$5K
- Lily LoveAlbuquerque$3K
- Thomas ReichCarlsbad$2K
- Brian HusenRio Rancho$2K
- Noah SymeAlbuquerque$2K
- Robert MartinAlbuquerque$2K
- Gregg SchmedesAlbuquerque$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.